- Trials with a EudraCT protocol (50)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
50 result(s) found for: Acute abdomen.
Displaying page 1 of 3.
EudraCT Number: 2009-014659-59 | Sponsor Protocol Number: SURE | Start Date*: 2010-04-20 | |||||||||||
Sponsor Name:U.O. Terapia Intensiva | |||||||||||||
Full Title: MANAGEMENT OF THE PATIENT WITH ACUTE Abdomen abdominal SURGERY UNDER URGENT: Multicentre randomized PILOT STUDY | |||||||||||||
Medical condition: Patients with acute abdomen in which to proceed is necessary to intervention in regime of urgency. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001309-14 | Sponsor Protocol Number: MINDED | Start Date*: 2016-10-20 | |||||||||||||||||||||||||||||||||||||||||
Sponsor Name:University of Heidelberg | |||||||||||||||||||||||||||||||||||||||||||
Full Title: Comparison of the efficacy of using a human acellular dermis (Epiflex®) against the surgical standard procedure for closing an open abdomen with respect to avoiding ventral hernia. A monocenter, ... | |||||||||||||||||||||||||||||||||||||||||||
Medical condition: open abdomen | |||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||
Trial protocol: DE (Completed) | |||||||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-002215-42 | Sponsor Protocol Number: 22/13 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:IRCCS Burlo Garofolo | |||||||||||||
Full Title: Single-blind randomized controlled trial for acute abdomen analgesia in Pediatric Emergency department | |||||||||||||
Medical condition: Analgesia in pediatric acute abdominal pain | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-005395-40 | Sponsor Protocol Number: NSAP-01 | Start Date*: 2007-05-03 | |||||||||||
Sponsor Name:Barts and The London NHS Trust | |||||||||||||
Full Title: Is Buscopan, paracetamol or a combination of both the most effective analgesia for the treatment of non-specific abdominal pain? | |||||||||||||
Medical condition: Adult subjects attending the emergency department complaining of acute abdominal pain | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-001729-38 | Sponsor Protocol Number: 6-1/13/2020/31 | Start Date*: 2021-07-02 |
Sponsor Name:Arnis Eņģelis | ||
Full Title: Clinical and economical efficiency and safety and inflammation parameter correlations study of concervative treatment of non-complicated acute appendicitis in 7 to 18 years old children. | ||
Medical condition: Acute non-complicated appendicitis in patients aged 7 to 18 | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: LV (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2017-000442-21 | Sponsor Protocol Number: RC17_0029 | Start Date*: 2017-09-12 | |||||||||||
Sponsor Name:CHU de Nantes | |||||||||||||
Full Title: Effects of perioperative administration of dexamethasone on postoperative complications and mortality after non-cardiac major surgery : a randomized, multicentre, double blind, study | |||||||||||||
Medical condition: non-cardiac major surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-003073-15 | Sponsor Protocol Number: 0504 | Start Date*: 2016-02-12 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Research Governance, University of Leicester | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: HYDration and bicarbonate to prevent acute Renal injury after endovascular Aneurysm repair: pilot-feasibility randomized controlled study (HYDRA pilot trial) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Acute kidney injury post endovascular repair of the abdominal aortic aneurysm. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2019-002348-26 | Sponsor Protocol Number: HUS-PERFECT | Start Date*: 2020-02-18 |
Sponsor Name:Helsinki University Hospital | ||
Full Title: Role of delay and antibiotics on PERForation rate while waiting appendECTomy – Randomized non-inferiority trial (PERFECT) | ||
Medical condition: Acute appendicitis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Completed) NO (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2019-000364-24 | Sponsor Protocol Number: ASST-2019-RADIO-ARCCS | Start Date*: 2019-09-03 | |||||||||||
Sponsor Name:AZIENDA SOCIO SANITARIA TERRITORIALE DEGLI SPEDALI CIVILI DI BRESCIA | |||||||||||||
Full Title: Randomized open label multicentric phase II trial of Adjuvant RadioChemotherapy, Concurrent versus Sequential, in resected non-small cell lung cancer (NSCLC) patients with mediastinal involvement (... | |||||||||||||
Medical condition: non small cell lung cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-005686-20 | Sponsor Protocol Number: 004 | Start Date*: 2012-08-20 | |||||||||||
Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. | |||||||||||||
Full Title: A Phase II, Randomized, Active Comparator-Controlled Clinical Trial to Study the Safety, Tolerability, and Efficacy of MK-7655 + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone in Patients ... | |||||||||||||
Medical condition: Patients with Complicated Intra-Abdominal Infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) ES (Prematurely Ended) PT (Completed) GR (Completed) LT (Completed) LV (Completed) EE (Completed) BG (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-011856-23 | Sponsor Protocol Number: ERNPL | Start Date*: 2009-09-16 | |||||||||||
Sponsor Name:OSPEDALE POLICLINICO S. MATTEO | |||||||||||||
Full Title: Evaluation of acute postsurgery pain management in patients who undergo inguen hernia surgery | |||||||||||||
Medical condition: Acute post surgery pain in patients who undergo inguen hernia surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-003818-92 | Sponsor Protocol Number: CURITIBA_TRIAL | Start Date*: 2014-12-22 | |||||||||||
Sponsor Name:Ospedale San Raffaele, UO Chirurgia Vascolare | |||||||||||||
Full Title: CUstodiol vs RInger: whaT Is the Best Agent? | |||||||||||||
Medical condition: Thoracoabdominal aortic aneurysm | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-001417-39 | Sponsor Protocol Number: FIBHGM-ECNC001-2022 | Start Date*: 2023-05-18 |
Sponsor Name:Fundación para la investigación biomédica del Hospital Gregorio Marañón (FIBHGM) | ||
Full Title: A phase IIb, double-blind clinical trial to compare the nephroprotection of cilastatin versus placebo in patients undergoing debulking surgery with intraoperative hyperthermic intraperitoneal chemo... | ||
Medical condition: Reduction of acute renal damage (days 1-7) (creatinine levels and KDIGO scale) in patients treated with CRS+HIPEC-cisplatin during the immediate postoperative period. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-008135-28 | Sponsor Protocol Number: 01-281108 | Start Date*: 2009-04-16 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Hull and East Yorkshire NHS Hospitals Trust | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Effect of Sildenafil on Pulmonary Artery Pressure during hypoxia and exercise in Chronic Heart Failure | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: We will investigate the effect of sildenafil on pulmonary artery pressure in Heart failure patients (impaired heart function). Patients will be recruited from the Heart Failure clinic at Castle Hil... | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2018-002547-29 | Sponsor Protocol Number: ATB-203 | Start Date*: 2019-11-21 | ||||||||||||||||||||||||||
Sponsor Name:Atox Bio | ||||||||||||||||||||||||||||
Full Title: Phase 2 randomized, double-blind, placebo-controlled, parallel-group study to evaluate the safety and efficacy of Reltecimod as compared to placebo in addition to standard of care in patients with ... | ||||||||||||||||||||||||||||
Medical condition: Acute kidney injury due to intra-abdominal infection/sepsis | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: FR (Completed) BE (Prematurely Ended) NL (Prematurely Ended) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2008-003281-25 | Sponsor Protocol Number: ALBIOS STUDY | Start Date*: 2008-04-17 | |||||||||||
Sponsor Name:OSPEDALE MAGGIORE DI MILANO (IRCCS) | |||||||||||||
Full Title: Efficacy of albumin administration for volume replacement in patients with severe sepsis or septic shock | |||||||||||||
Medical condition: Patients with severe sepsis or septic shock | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-000113-38 | Sponsor Protocol Number: UCL/05/177 | Start Date*: 2007-03-07 |
Sponsor Name:University College London | ||
Full Title: A randomised phase II double blind placebo controlled trial of Whole Brain Radiotherapy (WBRT) and Tarceva (OSI-774, erlotinib) in patients with advanced non-small cell lung cancer (NSCLC) with mul... | ||
Medical condition: Advanced non-small cell lung cancer with multiple brain metastases | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: Removed from public view |
EudraCT Number: 2009-014476-21 | Sponsor Protocol Number: CONKO-007 | Start Date*: 2013-02-22 | |||||||||||
Sponsor Name:Dekan of the Medical Faculty of the University Erlangen-Nuremberg; Prof. Dr. med. Markus F. Neurath | |||||||||||||
Full Title: Chemoradiation following induction chemotherapy in locally advanced, unresectable pancreatic cancer -a randomised phase 3 trial: Chemoradiation following induction chemotherapy compared with chemo... | |||||||||||||
Medical condition: Locally advanced non resectable pancreatic cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-004322-24 | Sponsor Protocol Number: ARN-509-003 | Start Date*: 2013-08-27 | |||||||||||
Sponsor Name:Aragon Pharmaceuticals, Inc | |||||||||||||
Full Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Study of ARN-509 in Men with Non-Metastatic (M0) Castration-Resistant Prostate Cancer | |||||||||||||
Medical condition: Castration-Resistant Prostate Cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: AT (Trial now transitioned) FI (Completed) SE (Completed) NL (Trial now transitioned) BE (Trial now transitioned) IT (Trial now transitioned) NO (Completed) DE (Trial now transitioned) ES (Ongoing) PL (Trial now transitioned) FR (Trial now transitioned) DK (Trial now transitioned) HU (Completed) CZ (Trial now transitioned) SK (Trial now transitioned) RO (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-003311-26 | Sponsor Protocol Number: 77839 | Start Date*: 2021-11-18 |
Sponsor Name:Prinses Máxima Centrum | ||
Full Title: DAVINCY trial: optimal Duration of (fos)aprepitant prophylaxis for nausea and Vomiting INduced by ChemotherapY in children: a double-blind placebo-controlled crossover randomized phase III trial’ | ||
Medical condition: prolonged anti emetic treatment | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Trial now transitioned) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
